PANACEA JOURNAL OF MEDICAL SCIENCES | 2021

Assessment of cardiovascular risk due to dyslipidemia by framingham score and using this information for early initiation of treatment of hypothyroidism and reducing the risk for cardiovascular events

 
 

Abstract


Materials and Methods: This study was planned and carried out in The Department of Medicine M.G.M.\xa0Medical College and M.Y. Hospital Indore, patients with subclinical Hypothyroidism not taking any\xa0treatment and patients of overt hypothyroidism not taking treatment coming to the OPD.\nStudy Design: Observational Study.\nResult: In normal subject, the mean Framingham score was 0.89 0.57%, while in subclinical\xa0hypothyroidism patients it was 1.78 1.4% mg/dL showing a higher mean Framingham score in subclinical\xa0hypothyroidism patients as compared to normal subjects and the difference was found to be statistically\xa0significant (P\nhypothyroidism patients as compared to normal subjects and the difference came out to be statistically\xa0significant (P\nConclusion: Overt and subclinical hypothyroidism both are associated with increased cardiovascular risk\xa0indicated by the higher values of Framingham risk in these patients as compared to normal controls.\xa0Mean Framingham risk was 3.31 2.82% in overt hypothyroidism patients, 1.78 1.4% in subclinical\xa0hypothyroidism and 0.89 0.57% in normal controls all of which were statistically significant[P\n\nKeywords:\xa0Cardiovascular,\xa0Dyslipidemia,\xa0Hypothyroidism & Framingham,\xa0Score.

Volume 11
Pages 82-85
DOI 10.18231/J.PJMS.2021.019
Language English
Journal PANACEA JOURNAL OF MEDICAL SCIENCES

Full Text